Expression and enhanced secretion of proteochondroitin sulphate in a metastatic variant of a mouse lymphoma cell line
- PMID: 3408644
- PMCID: PMC2246466
- DOI: 10.1038/bjc.1988.130
Expression and enhanced secretion of proteochondroitin sulphate in a metastatic variant of a mouse lymphoma cell line
Abstract
Even though many studies suggest that proteoglycans with their structurally determinative polysaccharide chains, the glycosaminoglycans (GAGs), are important mediators of cellular interactions, little is known about expression and possible functions of these macromolecules expressed by tumour cells during the transition from low to highly metastatic behaviour. Therefore, we investigated the cellular expression and secretion of GAGs in a syngeneic tumour system of DBA/2 mice consisting of a methylcholanthrene-induced low metastatic T lymphoma (Eb), its highly metastatic spontaneous variant (ESb), and a low metastatic derivative of ESb (ESb-MP), selected by its adherent growth properties. The [35S]-sulphate-labelled GAGs were isolated from in vitro cultivated cells and further characterized by separation on Sepharose CL 6B, on Mono-Q ion exchange chromatography, and alkali- and enzymatic digestion. In contrast to Eb-cells which produce chondroitin/dermatan sulphate (CS/DS) and heparan sulphate (HS) (cellular extract: CS/DS 67%, HS 33%; culture medium: CS/DS 61%, HS 39%) ESb- and ESb-MP-cells only express and secrete CS/DS. For ESb cells the CS portions consisted of 42% chondroitin-4-sulphate (CS-4) and 58% chondroitin-6-sulphate (CS-6), for ESb-MP cells of 23% CS-4 and 77% CS-6, for Eb cells of 16% CS-4 and 84% CS-6. The cell surface GAGs of the adherent variant ESb-MP contained a significantly higher portion of DS (65%) compared to ESb cells (25%). GAGs of all tumour cell lines studied had a mol. wt ranging from 35-40 kD compared to GAG molecular weight standards. Ion exchange chromatography indicated that differences in charge density between GAGs of these cell lines were minimal. These findings suggest that the different biological behaviour of the cell lines cannot be attributed to altered size and charge density of their GAG chains. However, highly metastatic ESb-cells secreted significantly more GAG than low metastatic Eb- and ESb-MP-cells. The possible consequences of the enhanced secretion of CS/DS by ESb-cells are discussed in terms of the postulated role of CS/DS in cellular adhesion, growth regulation and interactions with the immune system.
Similar articles
-
Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.Cancer Res. 1983 Jun;43(6):2704-11. Cancer Res. 1983. PMID: 6601984
-
Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma.Int J Biochem Cell Biol. 2003 Mar;35(3):376-90. doi: 10.1016/s1357-2725(02)00264-9. Int J Biochem Cell Biol. 2003. PMID: 12531251
-
Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.Int J Cancer. 1985 Apr 15;35(4):483-91. doi: 10.1002/ijc.2910350411. Int J Cancer. 1985. PMID: 3157649
-
Modern developments in mass spectrometry of chondroitin and dermatan sulfate glycosaminoglycans.Amino Acids. 2011 Jul;41(2):235-56. doi: 10.1007/s00726-010-0682-4. Epub 2010 Jul 15. Amino Acids. 2011. PMID: 20632047 Review.
-
Potential therapeutic application of chondroitin sulfate/dermatan sulfate.Curr Drug Discov Technol. 2008 Dec;5(4):289-301. doi: 10.2174/157016308786733564. Curr Drug Discov Technol. 2008. PMID: 19075609 Review.
Cited by
-
Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern.J Cancer Res Clin Oncol. 1989;115(6):554-7. doi: 10.1007/BF00391357. J Cancer Res Clin Oncol. 1989. PMID: 2606930 Free PMC article.
-
Role of Proteoglycans in Tumor Progression.Pathol Oncol Res. 1995;1(1):85-93. doi: 10.1007/BF02893590. Pathol Oncol Res. 1995. PMID: 11173574
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical